Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Spyre Therapeutics Inc., 3 years.
Spyre Therapeutics Inc.
Director
Acrivon Therapeutics Inc.
Director
Quanterix Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Quanterix Corporation June 9, 202690.0%
-
Acrivon Therapeutics Inc. June 20, 202499.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics Inc. | Grant or award | +9,366 | — | — |
| Jan 2, 2026 | Quanterix Corporation | Grant or award | +23,372 | — | — |
| Jan 2, 2025 | Quanterix Corporation | Grant or award | +7,435 | — | — |
| Oct 2, 2024 | Quanterix Corporation | Grant or award | +12,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.